Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.20
-0.10 (-1.89%)
At close: Feb 13, 2026
Market Cap23.55B +18.7%
Revenue (ttm)14.35B +1.0%
Net Income2.16B +2.9%
EPS0.47 +3.5%
Shares Out4.53B
PE Ratio11.03
Forward PE9.84
Dividend0.24 (4.54%)
Ex-Dividend DateOct 21, 2025
Volume12,355,020
Average Volume18,211,121
Open5.32
Previous Close5.30
Day's Range5.14 - 5.32
52-Week Range4.77 - 7.39
Beta0.20
RSI47.23
Earnings DateMar 26, 2026

About HKG:1066

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company’s medical device products include safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; and ... [Read more]

Sector Healthcare
Founded 1988
Employees 13,063
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1066
Full Company Profile

Financial Performance

In 2024, HKG:1066's revenue was 13.09 billion, a decrease of -1.08% compared to the previous year's 13.23 billion. Earnings were 2.07 billion, an increase of 3.24%.

Financial numbers in CNY Financial Statements